직접 급여 미생물(DFM) 시장 보고서 : 제품 유형, 가축, 제형, 지역별(2026년-2034년)

The global direct fed microbials market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.83% during 2026-2034. The market growth is significantly driven by escalating requirement for natural animal feed additives to enhance gut health and overall livestock performance. In addition, increasing awareness regarding antibiotic alternatives in animal feed and sustainable farming method further boosts market expansion across numerous regions.

DIRECT FED MICROBIALS MARKET ANALYSIS:

• Major Market Drivers: The increasing demand for natural and sustainable food additives, coupled with growing consumer awareness of gut health, is driving the growth of the direct fed microbials market.
• Key Market Trends: The trend towards clean label products and functional foods is propelling the adoption of direct fed microbials as natural alternatives to synthetic additives. Additionally, the rising interest in personalized nutrition and probiotics is creating new market opportunities for the market players.
• Geographical Trends: North America currently dominates the market, driven by a strong regulatory framework and consumer acceptance.
• Competitive Landscape: The market is characterized by a mix of established players and emerging startups. Major market players, including Cargill, Chr. Hansen, and ADM among others, compete based on product innovation, geographical reach, and regulatory compliance.
• Challenges and Opportunities: The industry faces challenges related to product standardization, regulatory hurdles, and consumer education. However, the growing demand for natural and functional ingredients presents significant opportunities for companies to expand their market share and develop innovative products.

DIRECT FED MICROBIALS MARKET TRENDS:

Rising Preference for Natural Feed Additives

The direct fed microbials market analysis indicates a significant shift toward natural feed additives as consumers as well as producers are increasingly focusing on sustainability and health in animal farming. Direct fed microbials, generally composed of beneficial bacteria or yeast, provide an effective alternative to synthetic additives and antibiotics commonly used in livestock production, and are increasingly being preferred for their high protein content. According to a research article published in April 2023, protein content in bacteria ranges between 53% to 80%. Besides, the new generation of animal feed , based on single cell protein, utilizes engineered microorganisms nutritionally tailored to the target animal. Moreover, these natural additives dominantly bolster the direct fed microbials market growth by enhancing digestive efficiency and boosting immunity, thereby reducing the need for antibiotics in animal feed. Furthermore, governments and regulatory bodies worldwide are encouraging the use of natural products in feed formulations to ensure safer meat and dairy products. This trend aligns with the broader consumer demand for cleaner, more natural food sources, thereby driving expansion in the direct fed microbials market. In addition, companies in the sector are capitalizing on this trend by developing new microbial strains and expanding their product portfolios to meet the increasing demand for antibiotic-free animal nutrition solutions.

Growing Product Applications in Poultry and Aquaculture Sectors

According to the direct fed microbials market forecast, the poultry and aquaculture industries are anticipated to remain key contributors to the growth of the global market. With the rapid elevation in demand for farmed seafood and poultry products globally, producers are actively exploring advanced solutions to optimize animal feed effectiveness as well as improve health. According to the World Wildlife Fund, globally, more than 3 billion individuals depend on farmed and wild-caught seafood as a substantial animal protein source. Direct-fed microbials exhibits a critical role in improving gut health, overall growth rates, and nutrient absorption in fish and poultry, resulting in an amplified interest from these industries. In poultry farming, microbials aid in mitigating general gastrointestinal complications, minimizing dependency on antibiotics and accelerating productivity. Analogously, in aquaculture, the utilization of direct fed microbials enhances both feed conversion ratios and water quality, catering to the magnifying requirement for effective and sustainable farming methods. Furthermore, as these sectors continue to expand, especially in countries with elevated protein consumption, the direct fed microbials market demand is expected to grow significantly.

Increasing Focus on Sustainable Livestock Farming

The direct-fed microbials market is also benefiting from the increasing focus on sustainable livestock farming practices. With rising environmental concerns and regulatory pressures to reduce the ecological footprint of animal agriculture, producers are adopting direct-fed microbials as a part of their strategy to enhance sustainability. As per industry reports, 41% of tropical deforestation is attributed to the conversion of land for cattle grazing purpose. Moreover, such microbials not only improve animal health and productivity but also contribute to better feed efficiency, resulting in reduced feed consumption and waste generation. In addition, the use of direct-fed microbials helps reduced greenhouse gas emissions by improving digestion and reducing methane production in ruminants. Governments and organizations promoting sustainable agriculture are supporting these practices through incentives and regulations, further boosting the adoption of direct-fed microbials. Furthermore, as sustainability becomes a central theme in global agriculture, the demand for eco-friendly and efficient feed additives is expected to grow, contributing to a positive direct fed microbials market outlook.

DIRECT FED MICROBIALS MARKET SEGMENTATION:

Breakup by Product Type:

• Lactic Acid Bacteria
• Bacillus
• Others

Lactic acid bacteria accounts for the majority of the market share

Breakup by Livestock:

• Swine
• Poultry
• Ruminants
• Aquatic Animals
• Others

Poultry holds the largest share of the industry

Breakup by Form:

• Dry
• Liquid

Dry represents the leading market segment

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest direct fed microbials market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for direct fed microbials.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the direct fed microbials industry include BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S), and Novus International Inc. (Mitsui & Co. Ltd).

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Direct Fed Microbials Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Lactic Acid Bacteria
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Bacillus
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Livestock

• 7.1 Swine
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Poultry
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ruminants
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Aquatic Animals
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Form

• 8.1 Dry
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Liquid
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 BASF SE
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Alltech
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 American Biosystems Inc
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Bayer AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Bio-Vet
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Cargill Incorporated
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Chr. Hansen A/S (Chr Hansen Holding A/S)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 DuPont de Nemours Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Kemin Industries
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Koninklijke DSM N.V.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Lallemand Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Novozymes A/S (Novo Holdings A/S)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Novus International Inc. (Mitsui & Co. Ltd)
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio